NASDAQ : PRCT

PROCEPT BioRobotics Corporation — Financial statements

Healthcare · Medical Devices · United States

Last price 19.2 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.10B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

PROCEPT BioRobotics Corporation (PRCT) reported revenue of 337.34M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue337.34M308.05M224.50M136.19M75.01M34.47M
Cost of Revenue123.59M111.83M87.40M65.14M37.93M18.61M
Gross Profit213.75M196.23M137.10M71.05M37.09M15.87M
Selling, General & Admin252.06M228.81M171.41M131.77M88.83M51.04M
Research & Development78.81M71.28M62.30M48.45M28.98M18.99M
Operating Expenses330.88M300.08M233.71M180.22M117.81M70.03M
Operating Income-117.13M-103.86M-96.61M-109.17M-80.72M-54.16M
Interest Expense-3.47M-3.59M-4.18M-4.00M-5.18M-5.81M
Interest & Investment Income8.26M12.22M10.89M7.55M2.50M76.00K
Other Non Operating Income (Expenses)-156.00K-156.00K-1.14M-203.00K-486.00K45.00K
EBT Excluding Unusual Items-112.50M-95.38M-91.05M-105.82M-83.90M-59.85M
Other Unusual Items2.90M-3.26M
Pretax Income-109.60M-95.38M-91.05M-105.82M-87.15M-59.85M
Income Tax Expense152.00K190.00K368.00K80.00K
Net Income-109.75M-95.57M-91.41M-105.90M-87.15M-59.85M
Net Income to Common-109.75M-95.57M-91.41M-105.90M-87.15M-59.85M
Shares Outstanding (Basic)56.35M55.54M52.12M47.26M44.40M16.48M
Shares Outstanding (Diluted)56.35M55.54M52.12M47.26M44.40M16.48M
EPS (Basic)-1.95-1.72-1.75-2.24-1.96-3.63
EPS (Diluted)-1.95-1.72-1.75-2.24-1.96-3.63
Free Cash Flow-84.92M-58.34M-103.62M-133.21M-83.03M-57.93M
Free Cash Flow Per Share-1.51-1.05-1.99-2.82-1.87-3.52
Gross Margin63.36%63.70%61.07%52.17%49.44%46.02%
Operating Margin-34.72%-33.72%-43.04%-80.16%-107.61%-157.12%
Profit Margin-32.53%-31.02%-40.72%-77.76%-116.18%-173.62%
Free Cash Flow Margin-25.17%-18.94%-46.16%-97.81%-110.69%-168.03%
EBITDA-110.08M-97.47M-91.38M-105.36M-77.88M-50.84M
EBITDA Margin-32.63%-31.64%-40.70%-77.36%-103.82%-147.48%
D&A For EBITDA7.05M6.39M5.23M3.81M2.84M3.32M
EBIT-117.13M-103.86M-96.61M-109.17M-80.72M-54.16M
EBIT Margin-34.72%-33.71%-43.04%-80.16%-107.61%-157.12%
Advertising Expenses600.00K500.00K300.00K100.00K100.00K

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents227.91M286.50M333.73M257.22M221.86M304.32M
Cash & Short-Term Investments227.91M286.50M333.73M257.22M221.86M304.32M
Receivables107.61M83.53M83.50M48.38M15.27M4.46M
Inventory77.06M70.69M56.17M39.76M28.54M13.15M
Prepaid Expenses7.21M9.21M8.10M5.15M6.17M4.24M
Restricted Cash777.00K
Other Current Assets496.00K438.00K357.00K60.00K
Total Current Assets420.29M450.38M481.84M350.57M272.63M326.17M
Property, Plant & Equipment48.60M47.94M45.65M48.99M32.14M8.32M
Other Intangible Assets571.00K709.00K932.00K1.20M1.48M1.75M
Long-Term Deferred Charges1.09M1.27M840.00K487.00K
Other Long-Term Assets8.80M7.78M4.75M3.47M3.09M777.00K
Total Assets479.35M508.08M534.02M404.72M309.33M337.02M
Accounts Payable15.07M17.29M10.03M13.50M9.39M2.03M
Accrued Expenses20.44M32.40M28.59M21.52M19.16M9.56M
Current Portion of Long-Term Debt2.00M1.89M
Current Portion of Leases2.50M2.21M1.91M1.68M2.13M2.10M
Current Unearned Revenue14.09M13.05M9.56M5.66M2.85M1.02M
Other Current Liabilities12.09M853.00K1.03M1.69M1.76M1.52M
Total Current Liabilities64.20M65.80M53.13M45.93M35.29M16.24M
Long-Term Debt51.72M51.62M51.47M51.34M52.99M51.50M
Long-Term Leases23.28M24.65M26.87M26.18M23.98M1.99M
Other Long-Term Liabilities91.00K147.00K324.00K517.00K200.00K
Total Liabilities139.28M142.21M131.80M123.97M112.26M69.93M
Additional Paid-In Capital1.04B1.01B948.09M735.24M545.75M528.67M
Retained Earnings-700.06M-641.56M-545.99M-454.57M-348.68M-261.52M
Comprehensive Income & Other22.00K37.00K114.00K84.00K-6.00K-54.00K
Total Common Equity340.07M365.87M402.22M280.75M197.07M267.09M
Shareholders' Equity340.07M365.87M402.22M280.75M197.07M267.09M
Total Liabilities & Equity479.35M508.08M534.02M404.72M309.33M337.02M
Total Debt77.50M78.48M82.25M81.09M79.10M55.60M
Net Cash (Debt)150.41M208.02M251.47M176.13M142.76M248.72M
Net Cash Per Share2.673.754.823.733.2215.09
Filing Date Shares Outstanding57.27M56.39M54.82M50.96M44.87M43.99M
Total Common Shares Outstanding57.25M56.32M54.72M50.77M44.83M43.68M
Working Capital356.09M384.58M428.71M304.64M237.34M309.93M
Book Value Per Share5.946.507.355.534.406.12
Tangible Book Value339.50M365.16M401.29M279.55M195.59M265.34M
Tangible Book Value Per Share5.936.487.335.514.366.08
Machinery34.17M25.82M21.79M16.51M4.57M3.96M
Construction In Progress778.00K4.11M262.00K3.55M5.67M
Leasehold Improvements13.22M13.22M12.49M12.36M4.94M4.94M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-109.75M-95.57M-91.41M-105.90M-87.15M-59.85M
Depreciation & Amortization7.05M6.39M5.23M3.81M2.84M3.32M
Stock-Based Compensation52.94M47.60M31.84M19.13M10.34M3.80M
Provision & Write-off of Bad Debts-77.00K219.00K840.00K
Other Operating Activities1.15M214.00K1.61M1.11M5.08M106.00K
Change in Accounts Receivable-27.07M-898.00K-35.96M-33.10M-10.81M-2.91M
Change in Inventory-10.26M-14.50M-17.23M-9.75M-15.25M-6.12M
Change in Accounts Payable3.83M6.65M-2.15M5.79M3.96M812.00K
Change in Unearned Revenue4.07M3.31M3.72M3.32M1.83M792.00K
Change in Other Net Operating Assets3.79M-2.40M4.30M7.59M8.78M2.73M
Operating Cash Flow-74.34M-48.98M-99.21M-108.00M-80.38M-57.33M
Capital Expenditures-10.59M-9.36M-4.41M-25.21M-2.65M-592.00K
Investing Cash Flow-10.59M-9.36M-4.41M-25.21M-2.65M-592.00K
Long-Term Debt Issued51.20M
Long-Term Debt Repaid-50.00M
Net Debt Issued (Repaid)1.20M
Issuance of Common Stock10.23M11.19M180.12M167.79M6.42M176.55M
Other Financing Activities-4.00M
Financing Cash Flow10.23M11.19M180.12M167.79M3.61M262.12M
Foreign Exchange Rate Adjustments-113.00K-74.00K
Net Cash Flow-74.80M-47.22M76.50M34.59M-79.42M204.19M
Free Cash Flow-84.92M-58.34M-103.62M-133.21M-83.03M-57.93M
Free Cash Flow Margin-25.17%-18.94%-46.16%-97.81%-110.69%-168.03%
Free Cash Flow Per Share-1.51-1.05-1.99-2.82-1.87-3.52
Levered Free Cash Flow-48.97M-23.92M-78.24M-106.37M-53.06M-36.81M
Unlevered Free Cash Flow-46.80M-21.67M-75.63M-103.88M-49.82M-33.18M
Cash Interest Paid3.30M3.46M3.97M4.06M4.29M4.75M
Change in Working Capital-25.64M-7.84M-47.33M-26.16M-11.49M-4.71M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.10B1.76B4.36B2.12B1.86B1.09B
Enterprise Value949.24M1.54B4.24B1.91B1.69B823.18M
Last Close Price19.2031.4680.5241.9141.5425.01
PS Ratio3.265.7119.4115.5424.7631.56
PB Ratio3.234.8010.837.549.434.07
P/TBV Ratio3.244.8110.867.579.504.10
EV/Sales Ratio2.815.0118.9014.0322.4823.88
Debt / Equity Ratio0.230.210.200.290.400.21
Net Debt / Equity Ratio-0.44-0.57-0.62-0.63-0.72-0.93
Net Debt / EBITDA Ratio1.372.132.751.671.834.89
Net Debt / FCF Ratio1.773.572.431.321.724.29
Asset Turnover0.680.590.480.380.230.15
Inventory Turnover1.721.761.821.911.821.80
Quick Ratio5.235.627.856.656.7219.01
Current Ratio6.556.849.077.637.7220.08
Return on Equity (ROE)-30.24%-24.89%-26.77%-44.32%-37.55%-36.49%
Return on Assets (ROA)-14.75%-12.46%-12.86%-19.11%-15.61%-14.62%
Return on Capital Employed (ROCE)-28.20%-23.50%-20.10%-30.40%-29.50%-16.90%
Earnings Yield-10.14%-5.44%-2.10%-5.00%-4.69%-5.50%
FCF Yield-7.72%-3.32%-2.38%-6.29%-4.47%-5.33%
Buyback Yield / Dilution-4.24%-6.56%-10.31%-6.43%-169.42%-349.90%